Demand Grows for Orthopedic Biomaterials in Europe

Changing demographics and lifestyle habits are increasing the incidence of typically age-related diseases, driving demand for orthopedic biomaterials across all age groups throughout Europe, according to a new report from Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm.

As a result, Frost & Sullivan analyst Eleni Grammenou finds that the European orthopedic biomaterials market revenues are expected to rise from U.S.$240 million in 2005 to an estimated $609 million in 2012.

As Europe's population ages, it will be accompanied by a surge in age-related orthopedic conditions and various musculoskeletal diseases. Likewise, traditionally age-related conditions such as osteoporosis and osteoarthritis will steadily increase among the younger population due to lifestyle changes such as smoking and poor nutrition, with sports and traffic-related injuries also claiming their toll on this group.

"The use of biomaterials has shown considerable clinical advantages and has been found to be particularly useful in a range of orthopedic applications including synthetic bone grafts, degradable fixation, and bone fillers,” said Mr. Grammenou. "Orthopedic biomaterials have also been found particularly useful in cranio-maxillofacial applications.”

However, the anticipated increase in demand will be challenged by cost-containment strategies affecting purchasing trends in the orthopedic braces and supports market, an alternative treatment option. In many cases, cost-cutting strategies being implemented by governments are driving hospitals to consider re-using orthopedic braces and support devices in an attempt to curb expenditures. These efforts will also affect the market for European orthopedic biomaterials.




Related Links:
Frost & Sullivan